abnormal lipid homeostasis_Cebpb<tm1Vpo>/Cebpb<tm1Vpo>

http://metadb.riken.jp/0002118I129SSvEvMF1Cebpbtm1VpoCebpbtm1VpoCebpbtm1Vpo

abnormal lipid homeostasis_Cebpb<tm1Vpo>/Cebpb<tm1Vpo>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• CCAAT/enhancer binding protein (C/EBP), beta
  http://metadb.riken.jp/db/mgi_rdf/MGI:88373

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cebpb<tm1Vpo>/Cebpb<tm1Vpo>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cebpb<tm1Vpo>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S/SvEv * MF1

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal lipid homeostasis
  http://purl.obolibrary.org/obo/MP_0002118

文献

http://purl.org/net/cito/citesAsAuthority

• L. Wang, et.al., Increased insulin receptor substrate-1 and enhanced skeletal muscle insulin sensitivity in mice lacking CCAAT/enhancer-binding protein beta., The Journal of biological chemistry, 2000, 275
  http://rdf.ncbi.nlm.nih.gov/pubmed/10747954
• S. Liu, et.al., Hypoglycemia and impaired hepatic glucose production in mice with a deletion of the C/EBPbeta gene., The Journal of clinical investigation, 1999, 103
  http://rdf.ncbi.nlm.nih.gov/pubmed/9916132